Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. (Q34157712): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Updated Item: Updating citation graph
Reinheitsgebot (talk | contribs)
Updated Item: Changing Karine Delange to Karine Delange (Q125191974) [#Papers ANS (was: SourceMD)]
 
(11 intermediate revisions by 8 users not shown)
label / astlabel / ast
 
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
description / ptdescription / pt
artigo científico
artigo científico (publicado na 2011)
description / pt-brdescription / pt-br
artigo científico
artigo científico (publicado na 2011)
description / hydescription / hy
գիտական հոդված
2011 թվականի հունվարին հրատարակված գիտական հոդված
description / ukdescription / uk
наукова стаття
наукова стаття, опублікована в січні 2011
description / astdescription / ast
artículu científicu
artículu científicu espublizáu en 2011
description / dadescription / da
videnskabelig artikel
videnskabelig artikel (udgivet 2011)
description / frdescription / fr
article scientifique
article scientifique (publié 2011)
description / hywdescription / hyw
 
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
description / fadescription / fa
 
مقالهٔ علمی
description / urdescription / ur
 
سائنسی مضمون
Property / author name string
Vincent des Portes
 
Property / author name string: Vincent des Portes / rank
Normal rank
 
Property / author name string: Vincent des Portes / qualifier
 
Property / author name string: Vincent des Portes / reference
stated in: Europe PubMed Central
PubMed publication ID: 21209411
retrieved: 31 July 2017
Timestamp+2017-07-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / author name string
Karine Delange
 
Property / author name string: Karine Delange / rank
Normal rank
 
Property / author name string: Karine Delange / qualifier
 
Property / author name string: Karine Delange / reference
stated in: Europe PubMed Central
PubMed publication ID: 21209411
retrieved: 31 July 2017
Timestamp+2017-07-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / authorProperty / author
Property / authorProperty / author
Property / author
 
Property / author: Vincent des Portes / rank
 
Normal rank
Property / author: Vincent des Portes / qualifier
 
Property / author: Vincent des Portes / qualifier
 
object named as: Vincent des Portes
Property / author: Vincent des Portes / reference
 
stated in: Europe PubMed Central
PubMed publication ID: 21209411
retrieved: 31 July 2017
Timestamp+2017-07-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / author
 
Property / author: Karine Delange / rank
 
Normal rank
Property / author: Karine Delange / qualifier
 
Property / author: Karine Delange / qualifier
 
object named as: Karine Delange
Property / author: Karine Delange / reference
 
stated in: Europe PubMed Central
PubMed publication ID: 21209411
retrieved: 31 July 2017
Timestamp+2017-07-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / language of work or name
 
Property / language of work or name: English / rank
 
Normal rank
Property / main subject
 
Property / main subject: fragile X syndrome / rank
 
Normal rank
Property / main subject: fragile X syndrome / reference
 

Latest revision as of 14:58, 28 March 2024

scientific article
Language Label Description Also known as
English
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
scientific article

    Statements

    Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. (English)
    Sébastien Jacquemont
    Maria Giulia Torrioli
    Elizabeth Berry-Kravis
    Baltazar Gomez-Mancilla

    Identifiers